根据血液检查和生命体征,预测心力衰竭患者的ICU死亡率
Yeao Wang1, Jianke Rong1, Zhili Wei1
1The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Frontiers in cardiovascular medicine
|July 10, 2025
概括
这项研究开发了一种机器学习模型,使用血液测试数据来预测心力衰竭重症监护室 (ICU) 患者的死亡率. 多层感知器模型在临床应用中显示出有前途的结果.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 医疗保健中的机器学习
背景情况:
- 心力衰竭是心血管疾病的一个主要并发症,死亡率很高.
- 现有的心力衰竭死亡率预测模型通常是复杂的,需要广泛的诊断.
- 在重症监护室 (ICU) 中的重症患者可能无法忍受广泛的测试,需要更简单的预测方法.
研究的目的:
- 开发一种更简单的,基于血液测试的模型,用于预测心力衰竭的ICU患者的死亡率.
- 评估各种机器学习算法在预测心力衰竭死亡率方面的性能,使用常规血液测试.
主要方法:
- 利用5,383名ICU患者 (eICU数据库) 的数据进行模型开发,530名患者 (MIMIC-IV数据库) 的数据进行外部验证.
- 包括人口,生理和生化数据,重点关注血液测试指标.
- 应用了严格的数据预处理和标准化,并训练了9个机器学习模型,包括后勤回归,SVM和神经网络.
主要成果:
- 特性选择确定了15个关键变量用于预测.
- 多层感知器 (MLP) 模型在评估的算法中获得了最高的性能.
- 对于死亡率预测,MLP显示F1得分为0.54,回忆率为0.71,精度为0.44.
结论:
- 使用随时可用的血液测试数据的MLP模型显示了预测ICU心力衰竭患者的死亡率的潜力.
- 这种方法为复杂的评分系统提供了一个更简单的替代方案,特别是在资源有限的环境中.
- 需要进一步验证,以确认这种基于机器学习的预测模型的临床实用性.
更多相关视频
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.4K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.2K
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
36
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
36
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
349
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
349
01:30Acute Coronary Syndrome III: Diagnostic Studies
25
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
25
01:30Heart Failure VII: Nursing Interventions
145
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
145
01:30Heart Failure IV: Classification and Diagnostic Evaluation
38
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
38
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
222
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222